ストックスクリーナーアプリを入手
0.3902
6.29%
0.0231
前日終値:
$0.3671
開ける：
$0.37
24時間の取引高:
418.32K
Relative Volume:
0.54
時価総額：
$35.95M
収益：
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.4288
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
+27.77%
1か月 パフォーマンス:
-28.90%
6か月 パフォーマンス:
-44.27%
1年 パフォーマンス:
-75.61%
1日の値動き範囲:
$0.3673
$0.41
1週間の範囲:
$0.2969
$0.4369
52週間の値動き範囲:
$0.2302
$1.60
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.394 | 33.49M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.71 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
799.57 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.28 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.13 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.05 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Institution Moves: Will Cue Biopharma Inc 1UC stock benefit from mergersTrade Risk Assessment & AI Forecast Swing Trade Picks - moha.gov.vn
Is Cue Biopharma Inc. stock attractive for growth ETFs2026 world cup usa national team semifinals top scorers high defensive line tactical prediction expert opinion - Улправда
2026 world cup lineups insights: Will Cue Biopharma Inc. stock benefit from AI adoption2026 world cup usa national team round of 32 young talents transition play tactical prediction insights - Улправда
Is Cue Biopharma Inc a good long term investmentStock Screening Results & Big Gains Low Budget - earlytimes.in
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Cue Biopharma stock: niche immunotherapy bet caught in a bruising small-cap biotech storm - AD HOC NEWS
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Cue Biopharma (CUE) price target increased by 25.00% to 5.10 - MSN
Working capital per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
Cue Biopharma prices $10M underwritten public offering; shares down - MSN
Can Cue Biopharma Inc. stock rebound after recent weaknessTreasury Yields & Verified Swing Trading Watchlists - Улправда
Will Cue Biopharma Inc. stock see insider buyingWeekly Trade Summary & Reliable Momentum Entry Alerts - Улправда
How Cue Biopharma Inc. (1UC) stock reacts to stronger dollarMarket Activity Report & Risk Controlled Swing Trade Alerts - Улправда
Published on: 2025-12-20 23:54:48 - moha.gov.vn
Cue Biopharma Signs Underwriting Agreement With H.C. Wainwright & Co. - TradingView — Track All Markets
Cue Biopharma prices $10 million public offering at $0.28 per share - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cue Biopharma (CUE) Launches $10 Million Public Offering with Wa - GuruFocus
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering - TipRanks
Cue Biopharma (CUE) Launches $10 Million Public Offering with Warrants - GuruFocus
Cue Biopharma announces pricing of $10 million public offering - marketscreener.com
Why retail investors pile into Cue Biopharma Inc. stock2025 Valuation Update & Safe Capital Growth Plans - ulpravda.ru
Cue Biopharma Announces Pricing of $10 Million Public Offering - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. (1UC) stock undervalued by metricsPortfolio Risk Report & Precise Trade Entry Recommendations - DonanımHaber
Why Cue Biopharma Inc. stock is seen as undervalued2025 Buyback Activity & Fast Gaining Stock Strategy Reports - DonanımHaber
How sustainable is Cue Biopharma Inc. stock dividend payoutQuarterly Risk Review & Safe Entry Point Alerts - DonanımHaber
How interest rate cuts could boost Cue Biopharma Inc. stockQuarterly Performance Summary & Daily Technical Stock Forecast Reports - DonanımHaber
Cue Biopharma launches public offering of common stock and warrants By Investing.com - Investing.com Australia
Insider Trends: Why retail investors pile into Cue Biopharma Inc. stockAnalyst Downgrade & Free High Accuracy Swing Entry Alerts - Улправда
Why Cue Biopharma Inc. stock remains resilientEarnings Growth Report & Weekly Setup with ROI Potential - Bölüm Sonu Canavarı
Will Cue Biopharma Inc. stock benefit from AI adoptionQuarterly Growth Report & Free Fast Entry Momentum Trade Alerts - Улправда
Cue Biopharma (CUE) Announces Proposed Offering with Key Managers - GuruFocus
Cue Biopharma launches proposed public offering of shares and warrants - MSN
Cue Biopharma stock tumbles on public offering announcement By Investing.com - Investing.com Canada
Cue Biopharma launches public offering of common stock and warrants - Investing.com
Cue Biopharma, Inc. Announces Underwritten Public Offering of Common Stock and Warrants - Quiver Quantitative
Cue Biopharma Announces Proposed Public Offering - GlobeNewswire
Autoimmune drug developer Cue Biopharma plans new stock and warrant sale - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Sahm
Cue Biopharma Earnings Notes - Trefis
Does Cue Biopharma Inc (CUE) offer a good opportunity for investors? - Setenews
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - Nasdaq
Cue Biopharma (CUE) Price Target Increased by 25.00% to 5.10 - Nasdaq
Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser
How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser
Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser
Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):